Jazz Pharmaceuticals
JAZZ
#1755
Rank
HK$94.17 B
Marketcap
HK$1,530
Share price
0.57%
Change (1 day)
93.85%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -HK$4.94 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are HK$4.26 Billion. a decrease over its 2024 earnings that were of HK$3.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -HK$4.92 Billion-233.49%
2024 HK$3.68 B57.87%
2023 HK$2.33 B-179.92%
2022 -HK$2.92 Billion230.37%
2021 -HK$0.89 Billion-141.02%
2020 HK$2.15 B-39.45%
2019 HK$3.55 B-14.2%
2018 HK$4.14 B20.03%
2017 HK$3.45 B-17.15%
2016 HK$4.17 B22.14%
2015 HK$3.41 B187.64%
2014 HK$1.18 B-50.79%
2013 HK$2.41 B73.63%
2012 HK$1.38 B41.69%
2011 HK$0.98 B116.61%
2010 HK$0.45 B262.77%
2009 HK$0.12 B-111.33%
2008 -HK$1.11 Billion1.31%
2007 -HK$1.09 Billion77.8%
2006 -HK$0.62 Billion36.59%
2005 -HK$0.45 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$128.08 B-2,704.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
HK$16.42 B-433.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-HK$18.74 Billion 280.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$16.85 B-442.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel